Clinical characteristics and outcome of multiple sclerosis in Korea

Does multiple sclerosis in Korea really differ from that in the Caucasian populations?

Su Hyun Kim, So Young Huh, Woojun Kim, Min Su Park, Suk Won Ahn, Joong Yang Cho, Byung Jo Kim, Ho Jin Kim

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Multiple sclerosis (MS) in Asia is thought to have different clinical characteristics from MS in Western countries; however, previous studies in Asia were performed without properly differentiating neuromyelitis optica (NMO) from MS. Objectives: To evaluate the clinical characteristics of MS in Korea after careful exclusion of potential explanations other than MS, particularly NMO spectrum disorder (NMOSD). Methods: This study is a retrospective review of consecutive MS patients attending five referral hospitals in Korea. All patients MS diagnoses were re-evaluated. Results: Of the 105 patients, 70 were female and 35 were male. The mean age of onset was 30.4 years and the mean disease duration was 5.4 years. On initial magnetic resonance imaging (MRI), 58% and 64% fulfilled the criteria for dissemination in space for the 2005 and 2010 McDonald criteria, respectively. Spinal cord lesions were observed in 78% of patients, primarily present as multiple small lesions with a mean length of 0.9 vertebral segments. The median time from disease onset to an Expanded Disability Status Scale 6 was 20 years. Conclusions: After careful exclusion of NMOSD, we found that the clinical pattern of MS in Korea does not fundamentally differ from that seen in Western countries.

Original languageEnglish
Pages (from-to)1493-1498
Number of pages6
JournalMultiple Sclerosis Journal
Volume19
Issue number11
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Korea
Multiple Sclerosis
Neuromyelitis Optica
Population
Age of Onset
Spinal Cord
Referral and Consultation
Magnetic Resonance Imaging

Keywords

  • Asia
  • beta-interferon
  • clinical characteristics
  • epidemiology
  • Korea
  • Multiple sclerosis
  • neuromyelitis optica
  • optic-spinal multiple sclerosis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Clinical characteristics and outcome of multiple sclerosis in Korea : Does multiple sclerosis in Korea really differ from that in the Caucasian populations? / Kim, Su Hyun; Huh, So Young; Kim, Woojun; Park, Min Su; Ahn, Suk Won; Cho, Joong Yang; Kim, Byung Jo; Kim, Ho Jin.

In: Multiple Sclerosis Journal, Vol. 19, No. 11, 01.01.2013, p. 1493-1498.

Research output: Contribution to journalArticle

Kim, Su Hyun ; Huh, So Young ; Kim, Woojun ; Park, Min Su ; Ahn, Suk Won ; Cho, Joong Yang ; Kim, Byung Jo ; Kim, Ho Jin. / Clinical characteristics and outcome of multiple sclerosis in Korea : Does multiple sclerosis in Korea really differ from that in the Caucasian populations?. In: Multiple Sclerosis Journal. 2013 ; Vol. 19, No. 11. pp. 1493-1498.
@article{ddacf5c3b6f74cb789ed5915ceed9f44,
title = "Clinical characteristics and outcome of multiple sclerosis in Korea: Does multiple sclerosis in Korea really differ from that in the Caucasian populations?",
abstract = "Background: Multiple sclerosis (MS) in Asia is thought to have different clinical characteristics from MS in Western countries; however, previous studies in Asia were performed without properly differentiating neuromyelitis optica (NMO) from MS. Objectives: To evaluate the clinical characteristics of MS in Korea after careful exclusion of potential explanations other than MS, particularly NMO spectrum disorder (NMOSD). Methods: This study is a retrospective review of consecutive MS patients attending five referral hospitals in Korea. All patients MS diagnoses were re-evaluated. Results: Of the 105 patients, 70 were female and 35 were male. The mean age of onset was 30.4 years and the mean disease duration was 5.4 years. On initial magnetic resonance imaging (MRI), 58{\%} and 64{\%} fulfilled the criteria for dissemination in space for the 2005 and 2010 McDonald criteria, respectively. Spinal cord lesions were observed in 78{\%} of patients, primarily present as multiple small lesions with a mean length of 0.9 vertebral segments. The median time from disease onset to an Expanded Disability Status Scale 6 was 20 years. Conclusions: After careful exclusion of NMOSD, we found that the clinical pattern of MS in Korea does not fundamentally differ from that seen in Western countries.",
keywords = "Asia, beta-interferon, clinical characteristics, epidemiology, Korea, Multiple sclerosis, neuromyelitis optica, optic-spinal multiple sclerosis",
author = "Kim, {Su Hyun} and Huh, {So Young} and Woojun Kim and Park, {Min Su} and Ahn, {Suk Won} and Cho, {Joong Yang} and Kim, {Byung Jo} and Kim, {Ho Jin}",
year = "2013",
month = "1",
day = "1",
doi = "10.1177/1352458513477712",
language = "English",
volume = "19",
pages = "1493--1498",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "11",

}

TY - JOUR

T1 - Clinical characteristics and outcome of multiple sclerosis in Korea

T2 - Does multiple sclerosis in Korea really differ from that in the Caucasian populations?

AU - Kim, Su Hyun

AU - Huh, So Young

AU - Kim, Woojun

AU - Park, Min Su

AU - Ahn, Suk Won

AU - Cho, Joong Yang

AU - Kim, Byung Jo

AU - Kim, Ho Jin

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Multiple sclerosis (MS) in Asia is thought to have different clinical characteristics from MS in Western countries; however, previous studies in Asia were performed without properly differentiating neuromyelitis optica (NMO) from MS. Objectives: To evaluate the clinical characteristics of MS in Korea after careful exclusion of potential explanations other than MS, particularly NMO spectrum disorder (NMOSD). Methods: This study is a retrospective review of consecutive MS patients attending five referral hospitals in Korea. All patients MS diagnoses were re-evaluated. Results: Of the 105 patients, 70 were female and 35 were male. The mean age of onset was 30.4 years and the mean disease duration was 5.4 years. On initial magnetic resonance imaging (MRI), 58% and 64% fulfilled the criteria for dissemination in space for the 2005 and 2010 McDonald criteria, respectively. Spinal cord lesions were observed in 78% of patients, primarily present as multiple small lesions with a mean length of 0.9 vertebral segments. The median time from disease onset to an Expanded Disability Status Scale 6 was 20 years. Conclusions: After careful exclusion of NMOSD, we found that the clinical pattern of MS in Korea does not fundamentally differ from that seen in Western countries.

AB - Background: Multiple sclerosis (MS) in Asia is thought to have different clinical characteristics from MS in Western countries; however, previous studies in Asia were performed without properly differentiating neuromyelitis optica (NMO) from MS. Objectives: To evaluate the clinical characteristics of MS in Korea after careful exclusion of potential explanations other than MS, particularly NMO spectrum disorder (NMOSD). Methods: This study is a retrospective review of consecutive MS patients attending five referral hospitals in Korea. All patients MS diagnoses were re-evaluated. Results: Of the 105 patients, 70 were female and 35 were male. The mean age of onset was 30.4 years and the mean disease duration was 5.4 years. On initial magnetic resonance imaging (MRI), 58% and 64% fulfilled the criteria for dissemination in space for the 2005 and 2010 McDonald criteria, respectively. Spinal cord lesions were observed in 78% of patients, primarily present as multiple small lesions with a mean length of 0.9 vertebral segments. The median time from disease onset to an Expanded Disability Status Scale 6 was 20 years. Conclusions: After careful exclusion of NMOSD, we found that the clinical pattern of MS in Korea does not fundamentally differ from that seen in Western countries.

KW - Asia

KW - beta-interferon

KW - clinical characteristics

KW - epidemiology

KW - Korea

KW - Multiple sclerosis

KW - neuromyelitis optica

KW - optic-spinal multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84884584439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884584439&partnerID=8YFLogxK

U2 - 10.1177/1352458513477712

DO - 10.1177/1352458513477712

M3 - Article

VL - 19

SP - 1493

EP - 1498

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 11

ER -